NCT03426891 2025-10-06
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
H. Lee Moffitt Cancer Center and Research Institute
Hospital San Carlos, Madrid
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
National Cancer Institute (NCI)